News
-
20 May, 2024
Spago Nanomedical uppdaterar om Tumorad-01 – studien framskrider enligt plan
-
20 May, 2024
Spago Nanomedical provides an update on Tumorad-01 – trial proceeds as planned
-
17 May, 2024
Nyttjandeperioden för Spago Nanomedicals teckningsoptioner av serie TO12 inleds idag
-
17 May, 2024
The exercise period for Spago Nanomedical’s warrants of series TO12 commences today
-
16 May, 2024
Spago Nanomedical publicerar årsredovisningen för 2023
-
16 May, 2024
Spago Nanomedical publishes the annual report for 2023
-
6 May, 2024
NOTICE TO ANNUAL GENERAL MEETING OF SPAGO NANOMEDICAL AB (PUBL)
-
6 May, 2024
KALLELSE TILL ÅRSSTÄMMA I SPAGO NANOMEDICAL AB (PUBL)
-
2 May, 2024
Spago Nanomedical delårsrapport januari-mars 2024
-
2 May, 2024
Spago Nanomedical interim report January-March 2024